00474.HK
Aceso Life Science Group Limited
HKSE · Industrials · Conglomerates · HK
HKD 0.14
−4.76%Year over year
Reported trailing growth
- Revenue
- +876.5%
- EBITDA
- -90.9%
- EBIT
- +66.0%
- EPS
- +35.8%
- Free cash flow
- +213.8%
- Operating cash flow
- +208.2%
Forward estimates
Based on analyst estimates
- Revenue
- —
- EBITDA
- —
- EPS
- —
Three-year CAGR
- Revenue
- -14.8%
- EBITDA
- —
- EBIT
- +89.3%
- Net income
- -93.7%
- EPS
- -89.0%
- Free cash flow
- -61.3%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Sep 1, 2025